A randomized trial of hydroxychloroquine as postexposure prophylaxis for covid-19. N. Engl. J. Med. 382, 517–525. doi:10.1056/NEJMoa2016638. CrossRef Full ...
2/n from @NEJM https://t.co/eTIksfGhXc
Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall tone confirms strong agreement with the study's findings that hydroxychloroquine does not prevent COVID-19 after exposure, with posts citing key studies from NEJM and other sources to reinforce this point. The tone is mostly factual and evidence-based, with some comments questioning previous beliefs and emphasizing the importance of rigorous clinical evidence.
Most discussions strongly support the conclusion that hydroxychloroquine is ineffective for post-exposure prophylaxis, citing multiple large studies and the NEJM publication.
While the reaction to the study is quite interested, some posts show curiosity about the study design and its implications, indicating moderate engagement with the topic.
Posts reference specific studies, mention statistical results, and criticize prior claims, reflecting a moderate level of analytical engagement.
The discussions emphasize that the study is a significant, consensus-based piece that challenges earlier claims about hydroxychloroquine's benefits, indicating high impact on public perception.
2/n from @NEJM https://t.co/eTIksfGhXc
@AngelGarciaMon8 Aquí tiene información al respecto. Un saludo. 1) https://t.co/WjEw1gSHvd 2) https://t.co/AYsJVKMSFl 3) https://t.co/i5Vj7lop8c 4) https://t.co/c6qA7AZCo5 5) https://t.co/Y9sn2Us37I 6) https://t.co/0MJE61lCKc 7) https://t.co/wEsu31zzFl
@thereal_truther Here is the HCQ trial that our centre was involved in: https://t.co/XeVllgSWTP
New England Journal of Medicine’da yayımlanan rastgele, çift-kör, plasebo kontrollü bir çalışmada, Covid-19’a orta riskli veya yüksek riskli maruz kalan kişilerde hidroksiklorokinin hastalığı önleyici etkisinin olmadığı gösterildi. https://t.co/k9198AJ3y8
- https://t.co/pdV34UU2rG - https://t.co/bL3scplBYF - https://t.co/8Jpg8Qx1Yd - https://t.co/jygiIfCzbp - https://t.co/xBrhYPhaAD - https://t.co/VKSO45pZNL - https://t.co/eC2bXAJoWZ - https://t.co/jktLGi3dPa - https://t.co/hgBxyASiRt - https://t.co/wmiwMyPkEl
@NicolodeGroot @jpogue1 Boulware et al study as found here doesn't include zinc in the methods. https://t.co/jDwrCLsIMg
This study review examines whether ivermectin, added to standard COVID-19 treatment, can reduce hospitalizations. It involves adults with confirmed COVID-19 in Corrientes, evaluating ivermectin's effectiveness in…
This study aims to determine if ivermectin, added to standard COVID-19 treatment, can reduce hospitalizations. It involves adults in Corrientes with confirmed COVID-19, assessing ivermectin's effectiveness in preventing…
This study tests if ivermectin, added to standard COVID-19 treatment, can reduce hospitalizations in adults with confirmed COVID-19. It uses a randomized, double-blind trial to evaluate ivermectin's potential in…
Seroprevalence of almost 30 in Delhi suggests infection fatality rate is as low as 0.06. A significant decline in new cases indicates progress towards herd immunity, with strong T cell responses playing a key role in…
Recent studies show that hydroxychloroquine is ineffective as postexposure prophylaxis for mild COVID-19 cases, with no significant difference in infection rates between drug and placebo groups, and increased mild side…
@Kevin_McKernan I've seen many studies of covid treatments that were designed to fail. Boulware is a master of designing studies to fail. E.g., https://t.co/yEy5aMWaBg >>
@CovidConfusion @Kevin_McKernan And doesn't work when given prophylactically 5 [end] https://t.co/u2Ci2EZkDj
Another high-profile correction (hydroxychloroquine) Article: NEJM RCT (Boulware et al., 2020) Relevant quote: “This randomized trial did not demonstrate a significant benefit of hydroxychloroquine…” New England Journal of Medicine Link: https://t.co/ImIHyYMALn
RT @TonJeanne: @GValeau @Lojodaskell_ @lonnibesancon @PiedNuke @grok @Nature Ne pas comprendre ce que l'on voit> idiotie. Meneguesso n'est…
@GValeau @Lojodaskell_ @lonnibesancon @PiedNuke @grok @Nature Ne pas comprendre ce que l'on voit> idiotie. Meneguesso n'est pas pris en compte. etudes Boulware et Meeus selon liens. https://t.co/WQEDVEqMjI https://t.co/vs1xNNQYpS Absence de dogmatisme de C19 >inclusion de Solidarity et Recovery Les references 335>341 ci dessous https://t.co/1NIWVhFST3
RT @Jikkyleaks: @69200mu @DrTessaT @JesslovesMJK @Kevin_McKernan @RWMaloneMD The Boulware study showed a 2% (16/821) secondary attack rate…
RT @Jikkyleaks: @69200mu @DrTessaT @JesslovesMJK @Kevin_McKernan @RWMaloneMD The Boulware study showed a 2% (16/821) secondary attack rate…
@69200mu @DrTessaT @JesslovesMJK @Kevin_McKernan @RWMaloneMD The Boulware study showed a 2% (16/821) secondary attack rate for PCR confirmed "COVID" in a population with known high risk exposure to a confirmed case. It is more likely they got it from another source. @AdhesionsOrg @JesslovesMJK @ClareCraigPath https://t.co/FPzWcKfBiA
@JDKearney411 @DrNeilStone Even more nope. https://t.co/G7ZKZ7MdfM
@thereal_truther Here is the HCQ trial that our centre was involved in: https://t.co/XeVllgSWTP
@Shirl3yBell @onuniversal_ [2] Hydroxychloroquine doesn’t work when given early https://t.co/8Hub3dmHux https://t.co/jZg7gfIHJf And doesn't work when given prophylactically https://t.co/u2Ci2EZSsR https://t.co/1bBmjqpRkJ Hydroxychloroquine can produce significant harm in some people.
@HestonChurchill @MeidasTouch Easy, the fact ivermectin and hydroxychloroquine were no better than placebo for Covid treatment and that people who took them instead of safe and effective vaccines put their lives at greater risk. https://t.co/8Fo22qjpnl https://t.co/g3lcwDTU1o
@MartinKulldorff Both ivermectin and hydroxychloroquine were proven in large studies reported in the New England Journal of Medicine to be no more effective than placebo. https://t.co/8Fo22qjpnl https://t.co/g3lcwDTU1o
@NurseMicheleRN Still no effect https://t.co/G7ZKZ7MdfM
@drsimonegold From the New England Journal of Medicine on hydroxychloroquine. No more effective than the placebo. Nice job putting lives at risk. https://t.co/g3lcwDTU1o
@PanDanTag @newstart_2024 Mostly handwaving and reference to a retracted study. Hydroxychloroquine doesn’t work when given early https://t.co/8Hub3dmHux https://t.co/jZg7gfIHJf And doesn't work when given prophylactically https://t.co/u2Ci2EZSsR https://t.co/1bBmjqpRkJ
@davideyoungmd @cappsie @djt10 @FillmoreWhite @mass_rising @BurgerLab12 @Scary7Dr @Lorenzo7127 @iXeno @CaryDavid722 @BlairHealt68622 @SkepticalMutant @CarlSmytheCells @PatrickSquirrel @DopplerEffect93 @trillionofcells @richykirsh @dag_waddell @PeterHotez @TorySnyc @higgsri @ncdave4life @ChrisJohnsonMD @exohalophiles @crabb_vicki @deerbrian @Earthdriver @DemsRRacePimps @BlueLionBlog @Alex_on_A14 @jtmayes3 @AndrewLazarus4 @TMGFlorida @Roper_Lab @ktibus @SecedeFromFools @dirk_fasshauer @RonMortimer3 @lasikeyecenter1 @Hanky1844607 @Awithonelison @NoGlobalist778 @EugeneBu @AcampbelTeacher @EdwardDS15 @VickiCoyle10019 @EdKrassen @LibertyLockPod @AlbertBourla with or without Azithromycin 3/n https://t.co/PKHdqMZFht Hydroxychloroquine doesn’t work when given early https://t.co/8Hub3dm9EZ https://t.co/jZg7gfI9TH And doesn't work when given prophylactically https://t.co/u2Ci2EZkDj https://t.co/1b
@drsimonegold https://t.co/fIfJyQxJ4p
@filipe_rafaeli https://t.co/ratJ9pekBC https://t.co/vEYG9EiNON https://t.co/vEYG9EiNON Vamos aos fatos então PRINCIPLE (Lancet, 2021): Resultados publicados aqui: HCQ não reduziu recuperação (OR 1.21; p=0.23) RCTs double-blind em tratamento precoce: Boulware et al. (NEJM, 2020): Sem
@matt_cread @DrNeilStone Because he disagreed with the MHRA's decision, which was also based on this paper https://t.co/tO8i1gm5TF
@PendulumRiding @DrNeilStone @JayMan471 https://t.co/G7ZKZ7MdfM
@ManuelHillebran @IanCopeland5 https://t.co/G7ZKZ7MdfM
@phil_lyman https://t.co/G7ZKZ7MdfM
@TheNationalGuy @NewsfromScience Which of these studies broke their protocols and how did you discover this magical insight? https://t.co/XPDUqloGlz https://t.co/G7ZKZ7MdfM https://t.co/DzF8QYBbAF
@Hant_Lum3 @_Buzzleclair_ @_JCAlain @ULHYSSE @Le_Figaro Non, il y avait des doutes sur les datas fournis par Surgisphere, l'étude a été retirée par ses propres auteurs, ce qui se fait régulièrement dans la recherche. Voici d'autres études sur l'inefficacité du HCQ: https://t.co/WAHKkhd3IF https://t.co/uzhadGitE6 Il y en a plein.
@Waakzaam @Coste1Costello @KThatzall This study shows that there is negligible difference between people taking hcl versus placebo for post exposure prophylaxis https://t.co/aAzBWNAjTp However this shows it's moderately effective in preventing covid19. https://t.co/OKaSWWT4MQ
@JimmyC1366 https://t.co/1HqtacNw9u https://t.co/zX7FzRQB1N
RT @PeterHotez: 2/n from @NEJM https://t.co/eTIksfGhXc
RT @PeterHotez: 2/n from @NEJM https://t.co/eTIksfGhXc
RT @PeterHotez: 2/n from @NEJM https://t.co/eTIksfGhXc
RT @PeterHotez: 2/n from @NEJM https://t.co/eTIksfGhXc
RT @PeterHotez: 2/n from @NEJM https://t.co/eTIksfGhXc
RT @PeterHotez: 2/n from @NEJM https://t.co/eTIksfGhXc
RT @PeterHotez: 2/n from @NEJM https://t.co/eTIksfGhXc
RT @PeterHotez: 2/n from @NEJM https://t.co/eTIksfGhXc
RT @PeterHotez: 2/n from @NEJM https://t.co/eTIksfGhXc
RT @PeterHotez: 2/n from @NEJM https://t.co/eTIksfGhXc
RT @PeterHotez: 2/n from @NEJM https://t.co/eTIksfGhXc
RT @PeterHotez: 2/n from @NEJM https://t.co/eTIksfGhXc
2/n from @NEJM https://t.co/eTIksfGhXc
@dad3children @JeromeAdamsMD https://t.co/G7ZKZ7MdfM
@TheObserver1901 Une étude critique notable concernant l'hcq, en particulier selon la posologie du protocole préconisé par Raoult, est celle publiée dans le NEJM. Cette étude, intitulée "A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19" https://t.co/McyQy6VPAI
@mameneghello @PauloJr19701970 @SomenteOrestes https://t.co/GDsjQzPN6A
@dninio @YouTube So anyway, this is the 'placebo' they used to 'discredit hcq', in the study published 3 months later. https://t.co/pVa7uwefXx
RT @FrancisHol59720: @filipe_rafaeli Burro, volta na primeira mensagem, o cara cira estudos 412 estudos, entre eles 39 com tratamento preco…
@filipe_rafaeli https://t.co/42B5VGCtCE
@filipe_rafaeli Burro, volta na primeira mensagem, o cara cira estudos 412 estudos, entre eles 39 com tratamento preconceito, eu postei um estudo sério que não funciona, se vc quiser um estudo randomizado sobre tratamento precoce toma aqui burro https://t.co/42B5VGCtCE https://t.co/LbHexSdBq0
@Fleurette_0 @ChatSecouriste @VictorSinclair3 @sandrousseau Essais RCT HCQ azythro Tang https://t.co/zeu5LJQfuM Chen (Jun) https://t.co/JcchnBgOKP Boulware (COVID-19 PEP) https://t.co/TgwIVEHanw Ulrich https://t.co/2M8aD2R8A5 Abella (PATCH) https://t.co/4xIctx7b8p
@SilverFoxBid1 @thejackhopkins Just gonna drop this here https://t.co/DyawTjovRG "After high-risk or moderate-risk exposure to Covid-19, hydroxychloroquine did not prevent illness compatible with Covid-19 or confirmed infection when used as postexposure prophylaxis within 4 days after exposure."
@NMoonitz @RealJacobPerry Ah I thought we were talking about your friend. That was tested extensively too. No harm, but also no benefit https://t.co/rOMMbsoj4q https://t.co/zcWSi3e7K5
@newstart_2024 Very eye-opening research! Ivermectin Trials: https://t.co/tgjQ8EegcV https://t.co/rh9nYe2x8L Hydroxychloroquine Trials: https://t.co/A98jOrkimA https://t.co/0etOdarHA8 https://t.co/ouDwxMQwMC Where the feud arose: https://t.co/EtO4HPZjqu Why it's false: https://t.co/pqSi9NuNYD
@LockedFab Les études en question : - https://t.co/5miwBL8sju - https://t.co/d1u7Nkhl0q
@AndreLu51031189 @gorg0noid https://t.co/zPW301s0De tratamentos que obtiveram a mesma taxa de cura de um placebo. boa
- https://t.co/pdV34UU2rG - https://t.co/bL3scplBYF - https://t.co/8Jpg8Qx1Yd - https://t.co/jygiIfCzbp - https://t.co/xBrhYPhaAD - https://t.co/VKSO45pZNL - https://t.co/eC2bXAJoWZ - https://t.co/jktLGi3dPa - https://t.co/hgBxyASiRt - https://t.co/wmiwMyPkEl
@MTnutz @GigiAnnluv @jestersatans @GetSchwifyinere @MeganSuspended HCQ isn’t effective. According to peer-reviewed double blind study in New England Journal of Medicine, more people died. https://t.co/A0rncpGk01 Ineffective as a prophylaxis https://t.co/vNzyeerJLs Lancet looked a multiple studies and confirmed: https://t.co/tXXsEm1OGF
@nicoguevar69406 @ZytoCher @fons_tom @laurenceteamhcl Une deuxième qui prouve qu’il n’y a aucune efficacité https://t.co/1MSqfEWiko
@BeWinstonSmith @Kevin_McKernan Here is another for you: https://t.co/UJq8PfaFCT
@MesaWindisms @GetSchwifyinere https://t.co/VivKBSq5Dz https://t.co/fUewB9mqCk https://t.co/Yn5LtXObQb
RT @Nopanaden: @AngelGarciaMon8 Aquí tiene información al respecto. Un saludo. 1) https://t.co/WjEw1gSHvd 2) https://t.co/AYsJVKMSFl 3) htt…
RT @Nopanaden: @AngelGarciaMon8 Aquí tiene información al respecto. Un saludo. 1) https://t.co/WjEw1gSHvd 2) https://t.co/AYsJVKMSFl 3) htt…
RT @Nopanaden: @AngelGarciaMon8 Aquí tiene información al respecto. Un saludo. 1) https://t.co/WjEw1gSHvd 2) https://t.co/AYsJVKMSFl 3) htt…
@AngelGarciaMon8 Aquí tiene información al respecto. Un saludo. 1) https://t.co/WjEw1gSHvd 2) https://t.co/AYsJVKMSFl 3) https://t.co/i5Vj7lop8c 4) https://t.co/c6qA7AZCo5 5) https://t.co/Y9sn2Us37I 6) https://t.co/0MJE61lCKc 7) https://t.co/wEsu31zzFl
@filipe_rafaeli Esse aqui é bonito, de 2020 ainda. https://t.co/2F7DsG0vNR
@AJasnowska70 @ProfitJim @JohnnyGoody3 @xazalbert Il y avait eu pas mal de chose, comme cette article qui évoque cela : https://t.co/yEUknccV8k Sinon on avait eu cette autre étude : https://t.co/yy32g8U5uU ou même des RCT en prévention mais post-exposition : https://t.co/4E9DyHYy2E https://t.co/UWBiWpLxQn
@CKellyUAP Go on Craig Kelly post us your cooker peer reviewed paper and I will show you thousands that prove it wrong; https://t.co/0rxARSsSXP https://t.co/FXCGSZcQfL https://t.co/xwA8Ms4NT0
@MelFarnwalt @LinKrenicki @PatriotSkyrific @Nettie7294 And nope. https://t.co/ziKhWzgXUU
@baric_branko @MRobertsQLD 2 Hydroxychloroquine doesn’t work when given early https://t.co/8Hub3dmHux https://t.co/jZg7gfIHJf And doesn't work when given prophylactically https://t.co/u2Ci2EZSsR https://t.co/1bBmjqpRkJ END
@JeremyFoub @pia_mapia @lonnibesancon @Beatrice_Rosen @MamansLouves D'autres études sont sorties dans la même période que le Lancet. Par exemple celle là, un RCT solide sur plus de 800 personnes, en traitement précoce, qui ne donnait aucun resultat. Donc oui ça ne faisait plus de doute, avec ou sans l'étude du Lancet. https://t.co/4E9DyHYy2E
@JlsRet51206 @Tsarorius La même semaine que la sortie de la fameuse étude du Lancet, et juste avant l'annonce de Veran, il y eu 2 autres etudes publiées, dont surtout une solide et fiable, RCT de plus de 800 personnes, avec HCQ en précoce. Et même là, aucun avantage. https://t.co/4E9DyHYy2E
@TommyvdWal https://t.co/kygk2Az4Hv
@TheChiefNerd https://t.co/G7ZKZ7MdfM
@TnAlistair There are RCTs that support and dismiss its use as a prophylaxis (see link below). Your own study states that the need has been superceded by effective vaccines (screenshot) The study I provided is about HCQ as a treatment where it simply doesn't work https://t.co/bL1zxriPCx https://t.co/Uxrce3KpBP
@yoshkapundrick @Erin1234565 Doesn’t work in early disease, either. https://t.co/Sr3vvpQ1Ae Or as a prophylactic. https://t.co/U5NLRnka8o
@JeremyFoub @lonnibesancon @VBaudoux Si vu que l’hcq est inefficace en prévention de la Covid: https://t.co/q1jnOWG3on https://t.co/3E1v9mkWp5
@lindeman126 @BlueScreenNPC @drclownworldMD @DschlopesIsBack @MdBreathe Here: https://t.co/vPpKjeCIF4 Here: https://t.co/szFd5k6okQ Here: https://t.co/8YeH6mS8Kk Boy, someone is big mad about something...
@P_J_Buckhaults Do you seriously think a paper by McCullough is going to be honest? Studies show that HCQ does nothing against COVID. https://t.co/cW8OfdEcuY https://t.co/iimTsuGOJM https://t.co/n7hJzAOwdJ https://t.co/NlFOAUP3pv
@JulienFort4bis @raoult_didier Les études ? https://t.co/rJFCFOH1g1 https://t.co/M3nSVkZM3B https://t.co/o4YYOsAY4U https://t.co/SObUjpV4Eb https://t.co/bhxwjl4997 Et il y en a tellement d'autres. En fait il y a en plus de 300, gros malin.
@Moondani17 @tezrh1 https://t.co/G7ZKZ7LFqe
@taurusg333 @raoulduke49 @bjurrows @Danny459673 @sduncanhealth @Arkout3 @crabb_vicki @TonyBaduy @ShaneAKAProp @JRNave @WendyOrent @mcfunny @DaveBla81093404 @Pouldeau61 @krebiozen @runhack @MsTrixter @TheFrankmanMN @Hurriquake @MONTMAN9500 @StuWizzle @Golfergirl2018 @dann58638436 @Scary7Dr @khoombu @BB0941167867205 @TakethatCt @AngryMouse23 @BigGuy4U86 @Kathmarval @AnnLove4All @encyclopath @1_TMF_ @Fornowago @FUDyou2 @Catheri49917567 @RadioColor @tonymac5 @groin_hammer @CyclopsSeesAll @doritmi @ScienceMonkey0 @Just4TheCause @zendogbreath @FormerAntivax @BruceFo43322941 @DK25769559 @BigBopp75348974 @provaxtexan @MarioMoney23 Provide evidence for "99.7% recovery rate" then factor in long covid. Ivermectin, hydroxychloroquine, with or without zinc does not work. https://t.co/3jEVT4pUdQ https://t.co/LUOqpZEtRe Steroids appear to be effective: https://t.co/kFoHwma0og
@allenf32 It doesn’t. You’d be shocked at how poor the data is in support of hydroxychloroquine. Utter trash. Randomized data are completely negative - as you’d expect for an anti-malarial that has no plausible mechanism of action against a virus. https://t.co/wdm2mvZiNG
@Danstringer74 https://t.co/ZrjK2damFx https://t.co/95H2nY2k7v https://t.co/JIx8bEXfJA a few studies that more or less show it was essentially useless in treating covid (unfortunately)
@AnnieThePoolmom @PierreKory with or without Azithromycin https://t.co/PKHdqN0d71 Hydroxychloroquine doesn’t work when given early https://t.co/8Hub3dmHux https://t.co/jZg7gfIHJf And doesn't work when given prophylactically https://t.co/u2Ci2EZSsR https://t.co/1bBmjqpRkJ [2/2]
RT @deNutrients: @JikkyKjj @Kevin_McKernan Excellent work both of you, much appreciated, but please... my nutrition bat radar had to double…
@delasttours Tiens, lis ça et on en reparle après
@HopeRising19 @CohranKim @eshpre I'm having a look. https://t.co/T9VyuHgZDj This cites Folate, B9, as the placebo. Seems odd when you take this into account
@dttpeople @richdatasci @dr_jon_l https://t.co/G7ZKZ7MdfM
@FriedaBerkelaar @Moondani17 with or without Azithromycin 2/n https://t.co/PKHdqN0d71 Hydroxychloroquine doesn’t work when given early https://t.co/8Hub3dmHux https://t.co/jZg7gfIHJf And doesn't work when given prophylactically https://t.co/u2Ci2EZSsR https://t.co/1bBmjqpRkJ 2/n
@sudokuvariante The data was hidden deep in the supplementary appendix. https://t.co/w9YeNWlu91
@jimmy_dore Hydroxychloroquine doesn’t work for COVID: https://t.co/TT2bAMCI7v https://t.co/7SyVf6rbex https://t.co/UB1k97tX1V https://t.co/S3C4KmDl4t
RT @malikhan07_: RIP hydroxychloroquine https://t.co/x21GeowgZL
@marc_g_wathelet @lawrie_dr “Every prophylaxis study is positive”?? Check the meta-analysis! (A proper one!) https://t.co/XBj6M322lZ https://t.co/U5NLRnka8o https://t.co/pDITPpVH41
@Willebike @Debunk_the_Funk https://t.co/G7ZKZ7MdfM
@iambatman967 @senatorbabet Here's another one of 800 patients that shows it's useless as well https://t.co/N3Va92vhe8
@brismich1 @mum89000 @MartinZ_uncut @aphm_actu
@RicardosTravels @PierreKory Stop showing me screenshots and provide actual links. One of them only had 20 people in the study. Larger scale studies showed to be ineffective. https://t.co/b7KA2atPpT https://t.co/n7hJzAOwdJ https://t.co/Mku2HZApQc https://t.co/cW8OfdEcuY
@WynterythTX @unhealthytruth @JusticeForFacts @farzyness “The incidence of new illness compatible with Covid-19 did not differ significantly between those receiving hydroxychloroquine and those receiving placebo” https://t.co/PnsR4FLcHX
@jucanabrefa @Sonic_urticant @jejedu67 @MathieuMolimard Celle là, entre autres… https://t.co/FquXGl0StY https://t.co/j9Xns12X6X https://t.co/AKi5xzrbYI
@jclacio2 @Dr_Steph_GAYET Visiblement tu ne sais pas lire. Faut dire que c'est de l'anglais et c'est écrit en terme scientifique. L'HCQ ne soigne pas le covid: https://t.co/oGNicu4LFH Ton déni des preuves médicales n'est pas pertinent, petit ignorant
@LucioMurilo1 @DrBrunoGino A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 https://t.co/0dkYCQRo6Y
@CarlosVecino4 @TheLancet A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 https://t.co/Cx4vL4GpPY
@NicolasAjMartin @MemeWally @LoLoWarn Non juste un essai clinique randomisé versus placebo publié après validation par les pairs comme ceux-ci qui montrent que l'HCQ ne sert à rien contre le Covid et comme l'IHU de Marseille a été incapable d'en faire. https://t.co/oGNicu4LFH https://t.co/pJJNij3SEj
@jimmy_dore A RCT of hydroxychloroquine showed no efficacy as a prophylactic measure against Covid. https://t.co/2R0MaEiIvk
@Acermendax Quelle est la posologie recommandée par les practiciens en prophylaxie ? Quelle est la posologie utilisée dans cette étude ? Différence ? Ne serait-ce pas une fraude scientifique? Elle ne serait pas un peu à géométrie variable la zététique? #Escroc https://t.co/Y7pLV0JJqK https://t.co/hMhC9LwRdH
@karrigell @BillardVincent @Acermendax Tu veux dire, comme celles-ci ? https://t.co/lzh9Y5FbO3 https://t.co/aW4YOgZBnD https://t.co/0xzupPT5Wz
@FreeMIN24465256 @chalumo @AnotherGenro @BonSens47865369 @VeritasNobis @rosewood2019 @QI_181 @SylvesterTiti @LgrdFred123 @GuisonJerome @JohnAlfredMorg1 @AlizeRenault1 @SebastienAeko @Odieux_Vulgaire @achilledamu @AlizeeRenault @Bravehawkspiri1 @OPECST_ @LeseulG @SoniadlpCaen @flolassarade @VillaniCedric @gerardlonguet55 @AssembleeNat @Senat Tiens, 100% d'études qui montre que l'HCQ ne protège pas du Covid, ne soigne rien du Covid et augmente la mortalité : https://t.co/m1bxpBBLa2 https://t.co/oGNicu4LFH https://t.co/pJJNij3SEj https://t.co/MLukFKa4St
@sudokuvariante @OsonsCauser @humanite_fr Etudes sur l'inefficacité de l'hydroxychloroquine : https://t.co/FquXGl0StY https://t.co/j9Xns12X6X https://t.co/AKi5xzrbYI https://t.co/U4gVGlXfs9 https://t.co/xeEufVzoA9 https://t.co/eIrP7nQZlJ https://t.co/hbTaIWOlXa https://t.co/nY2tJuMhmF
@757gb @amvtw @glossfar @ggiachet No tengo nada en contra, me alegraría si existiesen más soluciones farmacológicas. Que es lo que pasa cuando se hace un ECA en condiciones (aleatorizado doble ciego)?. Que la hidroxicloroquina no tiene efecto. https://t.co/EFcscZABNf
@kass12351 @ashbybrewer @davidaxelrod As for hydroxychloroquine, it has received more study, and the confidence of its trivial-to-no efficacy is higher. https://t.co/NB4FJGcK6D https://t.co/TWSEucEZ8H
@Tsadqiell @Esban_ Etudes sur l'inefficacité de l'hydroxychloroquine : https://t.co/FquXGl0StY https://t.co/j9Xns12X6X https://t.co/AKi5xzrbYI https://t.co/U4gVGlXfs9 https://t.co/xeEufVzoA9 https://t.co/eIrP7nQZlJ https://t.co/hbTaIWOlXa https://t.co/nY2tJuMhmF
@OunetPik @r_cluz @CocoCocoCocoVi1 @clouzeau_b Etudes sur l'inefficacité de l'hydroxychloroquine : https://t.co/FquXGl0StY https://t.co/j9Xns12X6X https://t.co/AKi5xzrbYI https://t.co/U4gVGlXfs9 https://t.co/xeEufVzoA9 https://t.co/eIrP7nQZlJ https://t.co/hbTaIWOlXa https://t.co/nY2tJuMhmF Bonne lecture.
@r_cluz @Lspjerem @CocoCocoCocoVi1 @clouzeau_b sur l'inefficacité de l'hydroxychloroquine : https://t.co/FquXGl0StY https://t.co/j9Xns12X6X https://t.co/AKi5xzrbYI https://t.co/U4gVGlXfs9 https://t.co/xeEufVzoA9 https://t.co/eIrP7nQZlJ https://t.co/hbTaIWOlXa https://t.co/nY2tJuMhmF
#001 A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 DOI: 10.1056/NEJMoa2016638
@markyrocks69 @OneGirlMelissa https://t.co/kjnsf0gZ2K
@OneGirlMelissa https://t.co/kjnsf0gZ2K
@darling_paris Bon alors deja de 1, la chloroquine ne marche pas. Ca a été prouvé par des dizaines d’articles et faut vraiment être con pour pas voir la vérité en face des yeux: https://t.co/yKuCDy3fsp https://t.co/eWFQwN2TFf https://t.co/Myp36VIZsJ https://t.co/G4emoijdoF
@NaZa_on @LazzariAmbrogio @MGrecoMD @vadoaberlino @GiacomoGorini https://t.co/F6Kmd8eBi8 https://t.co/6vjfFRxt23 https://t.co/Xt6OtNx4M7 https://t.co/l46ArRAx26 giusto qualcuno, ma ne è piena la letteratura.
@cwerph @ScottAdamsSays Here: https://t.co/r0sl794VE5 It did happen.
@epimeme Não melhorou em quadro de pacientes hospitalizados "A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM" https://t.co/PEqb8QCg81
@OsonsCauser @Thinker_View @LMucchielli https://t.co/1npa1MraZx https://t.co/CHt6RMerLH https://t.co/ebHstUovIp https://t.co/4aldbmMotu https://t.co/e97br8mTRI pas d'azithromycine poubelle.
@T33879 @GovRonDeSantis https://t.co/UZOU6Hr80Q
@HenkJZoer @LosCornelis @pjvanerp @ggvanloon @eaglehibma @Bourdonne @BorgerPieter Werkt niet. Hydroxychloroquine, which was widely used early during the pandemic, was shown to have no significant benefits in RCTs as pre-exposure prophylaxis https://t.co/YyDKrppg6V , as post-exposure prophylaxis https://t.co/qQPfuct8fR https://t.co/PlZclFK8zm 1/3
@francisherbers @pjvanerp Hydroxychloroquine, which was widely used early during the pandemic, was shown to have no significant benefits in RCTs as pre-exposure prophylaxis https://t.co/YyDKrpGRvv , as post-exposure prophylaxis https://t.co/qQPfucKJEr And https://t.co/PlZclG1JXW 1/3
@DonSather2 @phreakmac @nikoCSFB Doesn’t work as PEP: Boulware DR, Pullen MF, Bangdiwala AS, et al. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020;383(6):517-525. doi:10.1056/NEJMoa2016638
@phreakmac @nikoCSFB Also this, showing hcq likely doesn’t help in post-exposure prophylaxis either :/ Boulware DR, Pullen MF, Bangdiwala AS, et al. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020;383(6):517-525. doi:10.1056/NEJMoa2016638
@IngeJusta @ErasmusMC @UMCUtrecht Niet-gerandomiseerde onderzoeken worden overruled door wel-. De drie RCT's die HCQ in een vroeg stadium gegeven (= theoretisch grootste effect) onderzochten vonden geen effect: https://t.co/QjS3QWeJ4R, https://t.co/XNgM65NTmB en https://t.co/MePMEoAHZF.
@adbacchi @Kkbluestar https://t.co/ln0Tg2BMXD
@tayluthorx “A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19” título de um artigo desgraçado
@ElonBachman I have noticed similar susceptibility numbers indirectly corroborated by a number studies. The JAMA household infection study and a post exposure prophylaxis HCQ study spring to mind. https://t.co/0rQxQZyHPK https://t.co/ejWPlKURGV
@toadmeister I have seen this number indirectly corroborated by a number studies. The JAMA household infection study and a post exposure prophylaxis HCQ study spring to mind. https://t.co/0rQxQZyHPK https://t.co/ejWPlKURGV
@dondacamara @jjchamie HCQ is still useless, whether early COVID-19 symptoms or out-patient. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/fNG50bsmRF
@PenelopeVr46 @LaVeritaWeb Anche cercando trial randomizzati non se ne trova uno a favore dell'idrossiclorochina. Sarebbe meraviglioso se funzionasse, ma non è così. https://t.co/hLXk7a7QR6 https://t.co/5IfGKWrkZG https://t.co/SjUsf3XGIp https://t.co/uQGA7TMfe5
@Branquignol @T_Fiolet Boulware, prophylaxie post-exposition : pas d'effet mis en évidence. https://t.co/qhAqHPaQuk
@DusterDaroll @thehill “strong antiviral effects on SARS-CoV infection of primate cells” Cells in a dish. This is why they tried it. The randomized trial showed that it failed as treatment: https://t.co/s8xODYjRSR
@AbdenurFlavio @PedrooCava @schmittpaula @bramatti @filipe_rafaeli Boulware DR, Pullen MF, Bangdiwala AS, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med 2020 Aug 6;383(6):517–25. https://t.co/TYIyce5MyE
@Hannah74396083 I'm afraid since this article was written back in July last year numerous clinical studies and trials have found hydroxychloroquine does not prevent or treat coronavirus. For instance: https://t.co/86Ye2HpNjl https://t.co/5ljtMZEZdh https://t.co/KecSRTULTK https://t.co/fVB6JcDGb8
@AllambertD @exercitooficial https://t.co/l61Z3u7F0p - 821 participantes. 414 tomaram HCQ, outros 407 placebo. Não foi atestada nenhuma diferença significativa entre os dois grupos. https://t.co/EIuncdXIwV - agregado de fontes e levantamento que atesta a INEFICÁCIA do tratamento precoce.
@AllambertD @exercitooficial Zero é um número forte. Existem DIVERSOS: https://t.co/LWIlCtA3pB https://t.co/hYFVJcE529 https://t.co/ifB6jm4GXl https://t.co/bhdyRUeorV https://t.co/wkZoz3sAHq https://t.co/DbiMgsulGQ https://t.co/l61Z3u7F0p https://t.co/EIuncdXIwV
@AllambertD @eduard0aguiar @exercitooficial https://t.co/DbiMgsulGQ https://t.co/l61Z3u7F0p https://t.co/EIuncdXIwV
@filipe_rafaeli @dudelbem @luppinoreumato @ZamboniLab @AydaSchneider https://t.co/nfcv1pfjUS https://t.co/NusMT1Fqti https://t.co/Eyp2dvgLGH https://t.co/NLKCrbp8cy https://t.co/IlAWjPs4sZ https://t.co/weO57KOZEn https://t.co/FTbNheIszH https://t.co/dmVdUc8Ssk https://t.co/NQlYeYivqV https://t.co/sPKTjCW1Tj
"They wrote up the results in three days ... and ... sent two papers to The New England Journal of Medicine [showing that] hydroxychloroquine ... didn't work." https://t.co/pGDqntYPxw https://t.co/8v3FkNF0iW
@lucasgodinn @_alrac_v @machado787 @alexandregarcia Sobre o estudo "A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19" que, realmente enterrou HCQ, os autores foram claros. P=0,35 ou seja, 35% de chance do resultado esperado ocorrer sob hipótese nula.
@gordongekko369 @miri_1001 @evolving000 @WhiteHouse @MSN That is a study from 2005, which should already tell you that it is talking about a different virus. This one is actually talking about COVID 19 and comes to a different result: https://t.co/qASGDMLW6R believe me, it‘d be great if HCQ worked but it doesn’t...
@D_JLynch20 @ConceptualJames Here's a RCT for prevention https://t.co/vbrhSMEIaZ
@LuizCaetanoJun1 @Rconstantino 1. https://t.co/O7109nYqkv 2. https://t.co/SQEQH8d0qt
@paps56 Merci. Pour votre info, les 3 RCT auxquels les auteurs font référence sont les leurs : https://t.co/nwQIe4RiIw https://t.co/PDNP3mS1cq https://t.co/BEVacexbPt L'étude que vous pointez n'évaluait que la sécurité de l'HCQ, pas l'efficacité (qui l'était dans les 3 citées ici).
@Saulo_Silas @Raphael34460400 @ARConservador @AlmeidaPrb @jairbolsonaro Nem sei porque perco meu tempo passando. E como ensinar física quântica a um chimpanzé, com todo respeito a este primata . https://t.co/2jLGpIzlVp
❌ A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/VG3zs8r82C
And... we did a bit of Covid-19 work @DrEmilyMcD @MatthewPCheng along with great international teams (e.g. @boulware_dr , @srinmurthy99 and teams) https://t.co/yWHGC6cwbr https://t.co/uGKS8HBfuV https://t.co/oCnNidqswl https://t.co/6fHRvK8Zce https://t.co/0aQghoe4wY
@_a_muse_d_ @ksorbsinnrvoice @Mariucia1 @handheadman @P2Jeff @BuckSexton @realDonaldTrump Because they are wrong it is dangerous as a treatment and ineffective as a phrophylaxis. https://t.co/rjelPQKcnD
@EmeiMarkus @FabrizioDalCol @a_meluzzi Gli effetti collaterali sono noti da anni, i miglioramenti dei pazienti a marzo possono essere attribuiti agli altri farmaci usati. https://t.co/SjUsf3XGIp https://t.co/5IfGKWrkZG https://t.co/hLXk7a7QR6 https://t.co/uQGA7TMfe5
@ChimicoScettico @AntonelloZedda whoops link sbagliato. È https://t.co/QzNXKejGRs e il trial è https://t.co/2u8uO3hBpa Comunque ora meglio mi taccia, meglio tornare ai muoni :-)
@luly_pagz @JoaoCampoGrande @MarceloDMoraes @veramagalhaes Mas ja q vc quer tanto ver a opinião dos médicos olha esse estudo aqui sobre o tratamento ATÉ 4 dias, aliás o site é um dos q vc msm mandou https://t.co/bCtBHXhud4
@AlietaEck @MdSheryl @MSingletonMDJD @kksheld @AAPSonline Hydoxychloroquine does not work. Here are two RCT's on managing covid-19 outpatients as you suggested. https://t.co/ToRN2LaLwv https://t.co/wXNF2CZiLN
@zev_dr I see this study is cited on Norwegian medical authorities website as motivation for rejecting any use of Hydroxychloroiquine in outpatient treatment. It showed no benefit. The dose given seemed excessive ? And no use of zinc. Gun without the bullets ? https://t.co/IHOH2QxONa
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 https://t.co/YruNTvRwFt
@AIAseanjacoby https://t.co/6GgTyZa152
RT @giovannilandoni: #Hydroxychloroquine in various stages of #covid19 #SARSCoV2 and with no benefit in 3 mRCTs published in the #NEJM 3/…
RT @giovannilandoni: #Hydroxychloroquine in various stages of #covid19 #SARSCoV2 and with no benefit in 3 mRCTs published in the #NEJM 3/…
RT @giovannilandoni: #Hydroxychloroquine in various stages of #covid19 #SARSCoV2 and with no benefit in 3 mRCTs published in the #NEJM 3/…
#Hydroxychloroquine in various stages of #covid19 #SARSCoV2 and with no benefit in 3 mRCTs published in the #NEJM 3/ https://t.co/6LINbRUsif https://t.co/FJyTuZ5Z8g https://t.co/GcyDU8fWzd
@YossefMillul @Stalec_ Je leur ai transmis votre suggestion de lecture via commentaire YouTube ;) de mon côté j'ai trouvé celle la qui ne montre pas d'effet positif de hcq en préventif https://t.co/R8ZO5UHK8L
@Misha15011 @PutschMedia @DIVIZIO1 @raoult_didier @AssoCovid https://t.co/RvIRMaKKGj
@p25735 @Sage92377624 @chrislhayes How about the New England Journal of Medicine? https://t.co/n3Yb37qhfm
@Sage92377624 @p25735 @chrislhayes Here’s one that says it doesn’t. https://t.co/n3Yb37qhfm
@Rodrigo94975108 @t___santos @MahDeRecife @sudornelles @RdGuaibaOficial https://t.co/maZkNj0qKZ https://t.co/qpZJ6S8bSQ
@Noahpinion @netripy Here we go, there are some "inconclusive" results: https://t.co/cE0uJgo43c (Unknown month)
https://t.co/rouuIBvZvK
RT @fdzaraf: 誤りを指摘された医学誌掲載の3つの #ヒドロキシクロロキン 研究 A Randomized Trial of hydroxychloroquine as Postexposure Prophylaxis for Covid-19 Hydroxych…
@a_1_0_2 @Tiston1310 @raoult_didier Boulware DR, Pullen MF, BangdiwalaAS, et al.,A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19, N Engl J Med, 2020, 383(6):517-525
I wonder what prophylaxis people are talking about... People should follow IATF protocols on mass gatherings. Don't let our guard down #COVID19PH https://t.co/mJyTZkWEno
RT @fdzaraf: 誤りを指摘された医学誌掲載の3つの #ヒドロキシクロロキン 研究 A Randomized Trial of hydroxychloroquine as Postexposure Prophylaxis for Covid-19 Hydroxych…
誤りを指摘された医学誌掲載の3つの #ヒドロキシクロロキン 研究 A Randomized Trial of hydroxychloroquine as Postexposure Prophylaxis for Covid-19 Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19
Our mythbuster is based on this scientific research: “A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.” New England Journal of Medicine 383, no. 6 (August 6, 2020): 517–25. https://t.co/dqDjWZ4B8A #scicomm #research
@GrumpyOLSoldier A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/IAS0GRK2b6
@taoofthedow @mcfunny @jkellyca @GeoffSchuler @KStateTurk @ds_siete @ChristopherGDa4 @Charitable_Fury @flitesurgn @AndrewLazarus4 @FrankDElia7 @cch_ba @TsuDhoNimh @tarrimarkel @doritmi @jerfToni @emartinez78987 @WendyOrent @twitjunkie0124 @JaiKanta22 @BamaJeans24 @provaxtexan @handmadekathy @Olivia85689083 @itisjustmebabe @seraphina416 @JosephBlowe6 @DreadPirRob42 @LynnFynn3 @PongoHuston @TinFoilAwards @AgileConcept @Lynne0105 @MsTrixter @MrSandSMM @SMcMenemin @swedishchf @md444444444 @gluhwein11 @auscandoc @avalonii @jptlowy @TruthS33ker2 @a8drag @StahpL @ale_battini @lysandergrant @truthhealeruk @KSbyAuntieNic @ascendingdove11 This is one of the RCTs that has better evidence. https://t.co/Yq1VRk3kax
時事ネタとして すでにRCTが何本もあった After high-risk or moderate-risk exposure to Covid-19, hydroxychloroquine did not prevent illness compatible with Covid-19 or confirmed infection when used as postexposure prophylaxis within 4 days after exposure. https://t.co/Z25ksB1hvb
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/sCDanWAu3c
RT @MischaEDM: A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19: https://t.co/58fu7Nti95... Hydroxychloro…
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19: https://t.co/58fu7Nti95... Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence:https://t.co/58fu7Nti95... https://t.co/iphbLoNHJX
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 - https://t.co/u2GdpnOXWo
@BallouxFrancois HCQ has not been shown effective for early treatment in addition to lack of efficacy in hospital patients. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 https://t.co/oCrx8SO3BJ
@drakchaurasia @Dharmen46587056 @richardursomd @NileshKapoor63 @SajidJa23282468 @imacuriosguy @lydia967 @Mirror9110 @veryvirology @Ustangord @ProfSomashekhar @DrKKAggarwal @AAPSonline @ThinkActTank @ompsychiatrist @AnantBhan @Kaalateetham @giridar100 @CMichaelGibson @IMAIndiaOrg @ICMRDELHI @DrSubhasree @WHO @CDCgov @zev_dr A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 https://t.co/Bd0JrqM5wI
https://t.co/isi2pLUaRN submitted by /u/4252020-asdf [link] [comments] https://t.co/Yq8LmzMGzh
RT @UpdateonScience: https://t.co/3CCxqA7XXA A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 #sciencenews…
https://t.co/3CCxqA7XXA A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 #sciencenews https://t.co/3JrW77FkPQ
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 https://t.co/1CXniQVgVP https://t.co/XbFGAzrgUD
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 (Rated: Positive Bias) https://t.co/NFMWtQ4LBu
#Medicine A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 https://t.co/lrZmdTCUgE
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 https://t.co/1XJMM2LLtx
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 via /r/science https://t.co/vCsUr40B1R
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/3uTvkldU71
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/R46m4K5SVX
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/Ey7A3wO640
@gertvdijk Kende je deze al? Alleen gerandomiseerd op HCQ, maar een aardig grote studie. Weinig hoopgevend voor zink en vitamine C! https://t.co/XvHEgaTAGR https://t.co/29rQtf4PyY
HCQ doesn't work as a postexposure prophylaxis (given withing 4 days of exposure) after high-risk or moderate-risk exposure to Covid-19: A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 via @njem https://t.co/VqXa2TRTBV https://t.co/JW7UlbIpdw
RT @AndreZimerman: Participants recruited in social media. Enrolled themselves. Were randomized. Received med/placebo at home. Answered fol…
RT @AndreZimerman: Participants recruited in social media. Enrolled themselves. Were randomized. Received med/placebo at home. Answered fol…
Participants recruited in social media. Enrolled themselves. Were randomized. Received med/placebo at home. Answered follow-up questions. Exciting times. Digital clinical trials are coming! Link: https://t.co/a3WN0FoLp8 https://t.co/GjvCnErNBm
RT @Elie_benaim: I KNOW YOU ARE NOT A "MEDICAL PERSON". THIS IS WHY: NEW ENGLAND JOURNAL OF MEDICINE 1. Hydroxychloroquine with or withou…
I KNOW YOU ARE NOT A "MEDICAL PERSON". THIS IS WHY: NEW ENGLAND JOURNAL OF MEDICINE 1. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19 2. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. IF YOU KNEW HOW TO READ https://t.co/Jqk48V4QYx
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/V7PV9mq4Se
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/YD99GjNDyp
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/Bw1VJnO4mF
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/DXsW7Pgmsc Jeu Set et Match pour la prophylaxie!
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/wXutNb1Fzf
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/3UMKAQU9St
RT @KFSHRC_Research: A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for #Covid_19 https://t.co/MYjFPImrAm https://t.c…
RT @KFSHRC_Research: A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for #Covid_19 https://t.co/MYjFPImrAm https://t.c…
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for #Covid_19 https://t.co/MYjFPImrAm https://t.co/ZJNS2pZ3Br
@ProfTimNoakes A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/t3bLe3EHXh
@zev_dr lowcarbdoc (@zenindia74) Tweeted: A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/QhIvEIGqXn https://t.co/PIsx6bKM8E
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/QhIvEIGqXn
RT @eumed: Siete stati a stretto contatto con un positivo al virus SARS-CoV-2 e vi hanno consigliato di assumere l'idrossiclorochina? Rispa…
13. Boulware DR, Pullen MF, Bangdiwala AS, et al. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. New Engl J Med, 2020. https://t.co/dUsBxFlezY
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM @JamesTodaroMD what about this study and the funding of it.. https://t.co/0hY2gQ6usz
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/lx0mSzwK5V
Hoping all out there understand that HCQ is worthless in the prevention of COVID-19 A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/CcyIByThbF
NEJM: "A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19." https://t.co/SPrM5s1gut
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 https://t.co/Bd0JrqM5wI
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/IThivXMXUF
RT @fujikurok: Covid-19 に対する曝露後予防薬としてのヒドロキシクロロキンの無作為化試験 A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19…
Covid-19 に対する曝露後予防薬としてのヒドロキシクロロキンの無作為化試験 A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 The New England Journal of Medicine(日本国内版) https://t.co/4AZxXclzQj
A Randomized Trial of #Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | @NEJM Actual #evidencebasedmedicine regarding #HCQ. These aren’t case reports like those docs in the press conference. https://t.co/rwE9rl5gNH
RT @armycritcare: A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/4nDcnQjhMH
@allanldsantos Comprovação da ineficácia na profilaxia ou fase inicial? Além dos estudos em animais, tem esses: A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 - NEJM Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 - Annals of Intern Medicine
"hydroxychloroquine did not prevent illness compatible with Covid-19 or confirmed infection when used as postexposure prophylaxis within 4 days after exposure." A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/fXTecdS1P7
Post-exposure prophylaxis with hydroxychloroquine looking like no. Many flaws here but advances in chipping away at the hydroxychloroquine folklore. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/YAgvzxK6Fp
hydroxychloroquine did not prevent illness #COVID19 A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/m6q5GkfOEZ
コロナ暴露後ヒドロキシクロロキン(抗マラリア薬)をいっても感染予防できないことがわかった模様 A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/8OO7klQh04
@rwoolar @aziz0nomics @LitecoinPatrick @emore91 @brithume ]Boulware DR, Pullen MF, Bangdiwala AS, Pastick KA, Lofgren SM, Okafor EC, et al. (June 2020). "A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19". N. Engl. J. Med. doi:10.1056/NEJMoa2016638. You’re welcome.
A Randomized Trial of #Hydroxychloroquine as Postexposure Prophylaxis for #Covid_19 | NEJM https://t.co/XPjiZ3nyWk
RT @armycritcare: A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/4nDcnQjhMH
NEJM | A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 https://t.co/Qpu8Zu7Z4z https://t.co/62AvPDAfZV
RT @drdrew: Excellent study NEJM this afternoon. “A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19” David…
RT @AnantBhan: A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 https://t.co/0aC6CfWYla https://t.co/WAEtw…
RT @AnantBhan: A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 https://t.co/0aC6CfWYla https://t.co/WAEtw…
RT @AnantBhan: A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 https://t.co/0aC6CfWYla https://t.co/WAEtw…
RT @AnantBhan: A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 https://t.co/0aC6CfWYla https://t.co/WAEtw…
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 https://t.co/0aC6CfWYla https://t.co/WAEtwXoNuF
Ni como tratamiento ni como profilaxis A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/q2ux0dQGlM
Estudio del NEJM no se evidencia mejoria del COVID-19 con hidroxicloroquina. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/gKPEK5Heb2
#Hydroxychloroquine en prophylaxie du #COVID19 : Essai #Negatif A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 https://t.co/wnCEHbRiW4
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/8p4V4Czsdf
RT @drdrew: Excellent study NEJM this afternoon. “A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19” David…
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM. NO
RT @drdrew: Excellent study NEJM this afternoon. “A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19” David…
RT @drdrew: Excellent study NEJM this afternoon. “A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19” David…
RT @drdrew: Excellent study NEJM this afternoon. “A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19” David…
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/75dJ1YFKlh
RT @drdrew: Excellent study NEJM this afternoon. “A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19” David…
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/ZBCS5rUs86 Another nail in the Hydroxycholorquine coffin. No benefit for post-exposure prevention. RT please!
RT @drdrew: Excellent study NEJM this afternoon. “A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19” David…
@FreeBeeCee @Janqanon @9NewsPerth @Gary_Adshead @CraigKellyMP https://t.co/GAtJKPPN2B https://t.co/fyzxUHGGt1
@cookespring @GspotJake @zev_dr @ProfTimNoakes Correct...they've done more than 1. Here's 1. https://t.co/GAtJKPPN2B
@Sean60061139 @q_sc54 @zev_dr @ProfTimNoakes No - that was Mehera. This is Boulware et al - not withdrawn. https://t.co/19MuKoxk8G
@BooooZoooo @HRHbutnotusing @zev_dr Bullshit. https://t.co/19MuKoxk8G
@e_veritas_unum @ParanoidFactoid @gatewaypundit https://t.co/hkB2SX72qb
@DC_Draino @e_veritas_unum Double blind study of over 800 show no benefit better than placebo. Deal with it. https://t.co/2z1Ghw0I7Z
@gatewaypundit @e_veritas_unum You're lying to yourselves. https://t.co/2z1Ghw0I7Z
@nebre8ed @JamesTodaroMD No benefit: https://t.co/SSPCS955cu
@tanya_slobodian @NPR Oops: https://t.co/ukTZnXSyA6
@SpringSteps A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 - PubMed https://t.co/EYaASYD6cW
@NicolodeGroot @jpogue1 Boulware et al study as found here doesn't include zinc in the methods. https://t.co/jDwrCLsIMg
@Hericoni @VeganPantheist @Gabriel_Mbamelu @stella_immanuel https://t.co/v85Gexkbky
@NancyAMomarch @DavidBCollum https://t.co/371Eu57dQZ Conclusions: After high-risk or moderate-risk exposure to Covid-19, hydroxychloroquine did not prevent illness compatible with Covid-19 or confirmed infection when used as postexposure prophylaxis within 4 days after exposure.
@ProcterMd Do you just ignore research like this? https://t.co/tUtsMulrp5
scientific studies > internet videos with white coats and the aliens DNA and religion vaccine lady
A RCT of 821 patients: "After high-risk or moderate-risk exposure to COVID-19, hydroxychloroquine did not prevent illness compatible with COVID-19 or confirmed infection when used as postexposure prophylaxis within 4 days after exposure." https://t.co/Inf59VazxV
@MalufNicolau Prof, eu vejo boa ciência e muito dogmatismo político nessa discussão... Acho que é o mais precoce possível
@Zphyr90805533 @fluidloading @medicalfollower @humb_ang Et là encore, aucune efficacité. Idem en prise préventive : https://t.co/dC5M6URdOo Quand a Recovery, ça reste un des éléments de réponses sur l'efficace pour les cas grave (que vous le vouliez ou non, on peut débattre du risque de surdosage, mais les résultats sont là ;))
@quiscustodis @maheini @e_scel @BallouxFrancois @TheLancet @france_soir @Surgisphere This article was retracted: https://t.co/ZrGvcHOMT0 This article was NOT retracted: https://t.co/bttteLVfe6
@quiscustodis @maheini @e_scel @BallouxFrancois @TheLancet @france_soir @Surgisphere You sent me a retraction of a completely different article. How does it relate to this one? Why the dishonesty? https://t.co/bttteLVfe6
@quiscustodis @maheini @e_scel @BallouxFrancois @TheLancet @france_soir @Surgisphere You mean Ford? It's not a randomised, double-blind trial, thus not to be taken as conclusive, unlike this one: https://t.co/bttteLVfe6
@tmbrdux @e_scel @BallouxFrancois "Doctors I know" may well be seeing anecdotal benefits from the drug (or from immunity, how do they know), but unless proven through a real randomied double-blind clinical trial (like the one below showing inefficacy), that's not enough evidence: https://t.co/bttteLVfe6
@cabville @e_scel @BallouxFrancois This one is a golden standard study, not questionable, not withdrawn - https://t.co/bttteLVfe6
@jasoneiroz @raoult_didier Plazeboa eta hidroxiklorikina nahasten dituen itsu-bikoitz ikerketa baten arabera (Raoultek ez zuen egin hori, Sanofirekin interesak dituelako, noski), ez da plazeboa baino eraginkorragoa: https://t.co/cpYf0ZiKHJ https://t.co/IdKBhVDl8Q
#DIME_Recomienda Ensayo clínico aleatorizado doble ciego de @NEJM con una técnica de reclutamiento e inclusión de participantes con apoyo de en tecnología, redes sociales y servicio postal https://t.co/raIQn0i9VJ
@Crypto_bsl @swissinfo_en @CoronaEnglish for a recent one, for example here https://t.co/ocE7sIFwLl showing no significant prophylaxis effect of HCQ
@Emerson45448651 @TheCilas @Josefer70649021 @o_antagonista Confira esses artigos e tire suas dúvidas: https://t.co/Uqj5PoAhIu https://t.co/2GdCL0Pr0W https://t.co/yddLuWejGv https://t.co/IGVTeokVsC https://t.co/OSf1crtjuG
@Alessan01631490 @bruno_garbin @jairbolsonaro Seguem as pesquisas sobre a eficácia do uso profilático: https://t.co/vS5ShWVXmX https://t.co/2GdCL0Pr0W https://t.co/feDZXAFNLN https://t.co/h1ndZ5QBkC https://t.co/OSf1crtjuG
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/6pOmJKEjWd
@LeOptiflow @Coucouillee @raoult_didier si, souvent ils mentionnent le faible nombre de patients, le fait qu'il n'y ait pas eu de PCR etc. un ex, l'étude Boulware https://t.co/GyZSPHCtlA
@WM_apocaliptics @Medicina_CFM A ideia fazia sentido no início; para um projeto de pesquisa. Infelizmente não foi o caso. E os resultados foram igualmente frustrantes... https://t.co/csSEt5yqRI
RT @kuwamitsuosamu: 予防効果の治験はこの論文によって中止です。https://t.co/waMK4gdm5v
予防効果の治験はこの論文によって中止です。https://t.co/waMK4gdm5v https://t.co/GLgHjMBpCl
@ultrasylt @JusiMD @hsfi @AleksiReito @shamteppo @villesallinen @helsinkiuni @TampereUni @SuomenAkatemia @Laakarilehti @mediuutiset @amchelsinki @THLorg On annettu myös kuten ehdotat. Ainakaan toistaiseksi ei ole pystytty osoittamaan etua. https://t.co/yUJ1WrRhc5
@wordsinusername @ScottGottliebMD No. https://t.co/X9jCvz0s77
@NoLongerBennett @DogmanRespecter Still issues with this study but it’s the first real randomized human data. https://t.co/0OJC9cTfUg
Hidroxicloroquina en profilaxis postexposición para Covid-19 (ECA) https://t.co/fXmBeXfSwR /vía @fisterrae A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 https://t.co/cdB8rAVHtX
What stuck out to me most in this study wasn't that hydroxychloroquine did not statistically prevent post-exposure incidence of COVID - it was the results with the incidence of disease in the participants after exposure https://t.co/MIguOINdJ5
RT @air_garcia: Después de la exposición de riesgo alto o moderado a #Covid-19, la HCQ usada profilácticamente en los siguientes 4 días, no…
Después de la exposición de riesgo alto o moderado a #Covid-19, la HCQ usada profilácticamente en los siguientes 4 días, no previno la enfermedad compatible o la infección confirmada https://t.co/XmTfx7UODX
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 - PubMed https://t.co/8SoFoJyLGi
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/qXRVHXH6y8
@RoyPascal14 Mais juste pour vous, voilà la liste des études négatives **vraiment publiées** à ce jour : RCT : -Tang (https://t.co/0xigLdNENl) -Boulware (https://t.co/gIDLLRA1Ey) -Chen (https://t.co/4idRrJOltR) Obs : -Mahevas (https://t.co/zShHaS4cPU) -Geleris (https://t.co/AjlgQxi2oR)
@EarthTribeDawn Then there's this study of HCQ vs. placebo just came out. discouraging. https://t.co/Zvwn74zpJN "The incidence of new illness compatible with Covid-19 did not differ significantly between participants receiving hydroxychloroquine (49 of 414 [11.8%]) and those receiving placebo
RT @VCSTX: Remote #clinicaltrials: the new dawn for #healthresearch? A randomized trial of #Hydroxychloroquine as Postexposure Prophylaxi…
https://t.co/UZ18f4JVby #IndiaFightsCorona @ICMRDELHI
Remote #clinicaltrials: the new dawn for #healthresearch? A randomized trial of #Hydroxychloroquine as Postexposure Prophylaxis for #Covid19 #coronavirus #health #healthcare #medicalresearch #drugs #treatments #patients #research #clinicalresearch https://t.co/AoKSDxlNyh
I see strength in the absence of PCR in this study. It also makes it unique. https://t.co/L0vWJufWlr
No effect of HCQ in covid-19 prophylaxis https://t.co/ZZdyeIZRpI
@kaalzz1 @AnnalsofIM هذه الدراسة ..التي نقدها بالرسالة اعلاه ..غريبة كيف تستدل بالرد الذي فند عدم صحة المنهج https://t.co/NWdLU3rkKe
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
@TheLancet The University of Minnesota reported on Wednesday that #hydroxychloroquine did not help prevent illness in people exposed to SARS-CoV-2. https://t.co/rMnpFkHmob https://t.co/SwLOJtC9eG
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
La hidroxicloroquina no previene COVID-19 https://t.co/Ulnv5Jhgib
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/Rfk3qKaZs2
RT @micro_rp: A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://t.co/umTgeea6oK
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
Pillars of the structure called EBM not feeling very solid now. And on top of that, a third study that trashes the role of HCQ in prophylaxis. What say @KetPan https://t.co/U0pbguSgrH
RT @billndotnet: @RepGosar GFY, Paul. https://t.co/QJSPr3LSQJ Randomized, double blind, placebo controlled. 'Hydroxychloroquine did not…
@RepGosar GFY, Paul. https://t.co/QJSPr3LSQJ Randomized, double blind, placebo controlled. 'Hydroxychloroquine did not prevent illness compatible with Covid-19 or confirmed infection when used as postexposure prophylaxis within 4 days after exposure.'
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
@VPrasadMDMPH @load_dependent @mfkuepp @walidgellad Like this? https://t.co/4otczaNIbn
RCT finds no beneficial impact of malaria drug post-exposure to COVID, and some side-effects. "A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM" #COVIDー19 https://t.co/ifyPMvffBd
@Reap_What_U_Sow @seanmdav Alternative reading: https://t.co/QJSPr3LSQJ
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
RT @EricTopol: Remote, siteless, virtual, digitized clinical trials are taking hold, even for drug interventions Lots of buzz yesterday abo…
RT @DrewCareyMD: Another strike: #Hydroxychloroquine fails to prevent #coronavirus coronavirus infection in first double-masked #randomized…
@POTUS https://t.co/5nRdsv5imW glad you stopped the Plaquenil!
RT @rasittukel: New England Journal of Medicine’da yayımlanan rastgele, çift-kör, plasebo kontrollü bir çalışmada, Covid-19’a orta riskli v…
RT @rasittukel: New England Journal of Medicine’da yayımlanan rastgele, çift-kör, plasebo kontrollü bir çalışmada, Covid-19’a orta riskli v…
RT @rasittukel: New England Journal of Medicine’da yayımlanan rastgele, çift-kör, plasebo kontrollü bir çalışmada, Covid-19’a orta riskli v…
RT @rasittukel: New England Journal of Medicine’da yayımlanan rastgele, çift-kör, plasebo kontrollü bir çalışmada, Covid-19’a orta riskli v…
RT @rasittukel: New England Journal of Medicine’da yayımlanan rastgele, çift-kör, plasebo kontrollü bir çalışmada, Covid-19’a orta riskli v…
New England Journal of Medicine’da yayımlanan rastgele, çift-kör, plasebo kontrollü bir çalışmada, Covid-19’a orta riskli veya yüksek riskli maruz kalan kişilerde hidroksiklorokinin hastalığı önleyici etkisinin olmadığı gösterildi. https://t.co/k9198AJ3y8
@RepShipley
Use of hydroxychloroquine post COVID19 exposure does not prevent development of COVID19. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM https://www.nejm.org/doi/10.1056/NEJMoa2016638
"A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19": https://t.co/a7Y0y9CGHU
RT @DrewCareyMD: Another strike: #Hydroxychloroquine fails to prevent #coronavirus coronavirus infection in first double-masked #randomized…
Another strike: #Hydroxychloroquine fails to prevent #coronavirus coronavirus infection in first double-masked #randomized #controlled #trial in people with high and moderate risk #exposure #COVIDー19 #COVID #Covid_19 #CoronavirusOutbreak #RCT https://t.co/dQrkuRwHB1 https://t.co/DD5W6gUMHV
forgot to leave a link to the study. My bad. Thanks @misterchambo for pointing out the oversight https://www.nejm.org/doi/full/10.1056/NEJMoa2016638
HCQ na profilaxia pós-exposição. https://t.co/0dpnqcKHHl
The NEJM article is now live, and we’re adding the link to my story. https://www.nejm.org/doi/10.1056/NEJMoa2016638
A randomized trial of hydroxychloroquine as postexposure prophylaxis for covid-19. N. Engl. J. Med. 382, 517–525. doi:10.1056/NEJMoa2016638. CrossRef Full ...
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org. Michael Ocheje. 1 ...
org/doi/full/10.1056/NEJMoa2016638. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 | NEJM. NEJM.ORG. A Randomized Trial of ...
org/doi/full/10.1056/NEJMoa2016638 18) RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational ...
2020. A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19. N Engl J Med ...
In this randomized clinical trial of 1821 patients with mild to moderate COVID ... A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for COVID- ...
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Source: New England Journal of Medicine. Pre-exposure hydroxychloroquine ...
A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med Overseas Ed 2020:NEJMoa2016638.doi:10.1056/NEJMoa2016638.
... hydroxychloroquine for pre-exposure or post-exposure prophylaxis of SARS-CoV-2 infection and in the treatment of patients with mild COVID-19 in terms of ...
A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. New England Journal of Medicine. 2020 Jun 3. 14. Watanabe M. Efficacy of ...
A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. DR Boulware, MF Pullen, AS Bangdiwala, KA Pastick, SM Lofgren, ... New ...
A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. ... A cluster-randomized trial of hydroxychloroquine for prevention of Covid ...
... COVID-19 disease: a randomized controlled trial. ... A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19.
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020;383(6):517-525. https://doi.org/10.1056/NEJMoa2016638
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. DR Boulware et al. After high-risk or moderate-risk exposure to Covid-19 ...
... 10.1056/NEJMoa2016638). June 8, 2020, Research Update. Systematic Review: Fever, Cough, Elevated C-Reactive Protein, and Ground Glass Opacities Common in ...
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. DR Boulware et al. After high-risk or moderate-risk exposure to Covid-19 ...
N Engl J Med, 2020, doi:10.1056/NEJMoa2016638. Dr I.D.. 7 RéactionsCommenter; Partager sur Facebook. Facebook. Partager sur X. X. Partager sur Linkedin.
N Engl J Med. 2020;NEJMoa2016638. doi: 10.1056/ NEJMoa2016638 5. 5. Kalil AC. Treating COVID-19-off-label drug use, compassionate use, and randomized ...
A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19 [e-pub ahead of print]. N Engl J Med. https://doi.org/10.1056/NEJMoa2016638.
doi: 10.1056/NEJMoa2016638. Online ahead of print. PMID: 32492293. Share Facebook LinkedIn X Copy Link Print Email. Title: Disulfiram-like Reaction with ...
Pastick, S.M. Lofgren, E.C. Okafor, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19. N Engl J Med, 383 (2020) ...
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638. Epub ...
Boulware DR, Pullen MF, Bangdiwala AS, et al. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med 2020. Epub ...
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. DR Boulware et al. After high-risk or moderate-risk exposure to Covid-19 ...
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020 Aug 6;383(6):517-525. doi: 10.1056/NEJMoa2016638.
org/doi/full/10.1056/NEJMoa2016638 18) RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a ...
org/doi/full/10.1056/NEJMoa2016638 There is no good evidence that it works in combination with other therapeutics (zinc or azithromycin).
org/doi/full/10.1056/NEJMoa2016638 There is no good evidence that it works in combination with other therapeutics (zinc or azithromycin).
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
... 10.1056/NEJMoa2016638. И о локдауне: не миф, что он ухудшил привычки здоровья многих людей. Мы стали меньше двигаться, хуже питаться, выросло ...
org/10.1056/NEJMoa2016638 Patel, P., Binnicker, M. J., Diekema, D. J., & Kobayashi, M. (2021). Report: Current status and future of ...
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
... 10.1056/NEJMoa2016638 https://nejm.org/doi/full/10.1056/nejmoa2012410 https://nejm.org/doi/full/10.1056/NEJMoa2019014 NIH and the WHO ...
org/doi/full/10.1056/NEJMoa2016638 There is no good evidence that it works in combination with other therapeutics (zinc or azithromycin) ...
doi: 10.1056/NEJMoa2016638. pmid:32492293. 11. Syed F, Hassan M, Arif MA, Batool S, Niazi R, Laila UE, et al. Pre-exposure Prophylaxis With ...
... 10.1056/NEJMoa2016638; Veklury (remdesivir) [product information]. Foster City, CA, Gilead Sciences. Accessed Oct. 23, 2020 at https://www ...
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med 2020;383:517-25. [Crossref] [PubMed] ...
... a randomized trial of stress ulcer prophylaxis ... A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
... 10.1056/NEJMoa2016638 https://nejm.org/doi/full/10.1056/nejmoa2012410 https://nejm.org/doi/full/10.1056/NEJMoa2019014 NIH and the WHO ...
A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. ... (COVID-19) in healthcare workers: a randomized trial.
... prophylaxis (PEP) for the prevention of COVID-19 was ... A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19.
... trials of post-exposure prophylaxis, pooled and by study ... A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
... 10.1056/NEJMoa2016638 https://nejm.org/doi/full/10.1056/nejmoa2012410 https://nejm.org/doi/full/10.1056/NEJMoa2019014 NIH and the WHO ...
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org. Michael ...
Boulware DR, Pullen MF, Bangdiwala AS, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19. N Engl J Med ...
... 10.1056/NEJMoa2016638 https://nejm.org/doi/full/10.1056/nejmoa2012410 https://nejm.org/doi/full/10.1056/NEJMoa2019014 NIH and the WHO ...
Boulware DR, Pullen MF, Bangdiwala AS, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19. N Engl J Med.
26. Boulware, DR ∙ Pullen, MF ∙ Bangdiwala, AS ... A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19. N ...
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med . 2020 Aug;383(6):517–25. OpenUrlCrossRef ...
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-. 19. N Engl J Med. 2020 Aug;383(6):517–25. 8. Rathi S, Ish P ...
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
org/doi/full/10.1056/NEJMoa2019014 https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638 https://www.medrxiv. org/content/10.1101/2020.07 ...
doi: 10.1056/NEJMoa2016638. pmid:32492293. 16. Rodríguez-Molinero A, Pérez-López C, Gálvez-Barrón C, Miñarro A, Macho O, López GF, et al ...
et al. (2020) A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19. N Engl J Med ...
... 10.1056/NEJMoa2016638 https://nejm.org/doi/full/10.1056/nejmoa2012410 https://nejm.org/doi/full/10.1056/NEJMoa2019014 NIH and the WHO ...
Boulware DR, Pullen MF, Bangdiwala AS, et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for covid-19. N Engl J Med ...
A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med. 2020; 383:517-525. Crossref · Scopus (989).
... 10.1056/NEJMoa2016638 https://nejm.org/doi/full/10.1056/nejmoa2012410 https://nejm.org/doi/full/10.1056/NEJMoa2019014 NIH and the WHO ...
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19. N Engl J Med. 2020; 383: 517-525. 10.1056/NEJMoa2016638.
... 10.1056/NEJMoa2016638 https://nejm.org/doi/full/10.1056/nejmoa2012410 https://nejm.org/doi/full/10.1056/NEJMoa2019014 NIH and the WHO ...
A randomized trial of hydroxychloroquine as postexposure prophylaxis for COVID-19. N Engl J Med. 2020; 383:517-525. Crossref · Scopus (975).
A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med. 2020; 383: 517-525. View in Article. Scopus ...
A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med. 2020;383(6):517–25. doi: 10.1056 ...
doi: 10.1056/NEJMoa2016638 pmid:32492293; PubMed Central PMCID: PMC7289276. 76. Skipper CP, Pastick KA, Engen NW, Bangdiwala AS, Abassi M ...
A randomized trial of hydroxychloroquine as postexposure prophylaxis for covid-19. N Engl J Med. 2020;383:517-525. [PMID: ] doi: 10.1056 ...
org/doi/full/10.1056/NEJMoa2016638 + https://www.sciencedirect. com/science/article/pii/S1198743X203 0505X?fbclid=IwAR1ZsvFlijoiVziG_ePLz ...
A randomized trial of hydroxychloroquine as postexposure prophylaxis for covid-19. N Engl J Med. 2020;383:517-525. [ 32492293] doi: 10.1056 ...
https://www.nejm.org/doi/full/10.1056/NEJMoa2016638. After high-risk or moderate-risk exposure to Covid-19, hydroxychloroquine did not ...
A randomized trial of hydroxychloroquine as postexposure prophylaxis for covid-19. N. Engl. J. Med. 383, 517–525. doi:10.1056/NEJMoa2016638.
Boulware, DR ∙ Pullen, MF ∙ Bangdiwala, AS ∙ et al. A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N ...
... study was needed to demonstrate their efficacy in Covid ... A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
DOI: 10.1056/NEJMoa2016638 DOI: 10.1136/bmj.m1849 DOI: 10.1056/NEJMoa2021436 .
... COVID-19 [16]. A randomized trial of postexposure prophylaxis using hydroxychloroquine did not reveal any protective effect of developing ...
A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. ... prevention or early-phase treatment of coronavirus ...
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020. DOI:10.1056/NEJMoa2016638. About the ...
... 10.1056/NEJMoa2016638 https://nejm.org/doi/full/10.1056/nejmoa2012410 https://nejm.org/doi/full/10.1056/NEJMoa2019014 NIH and the WHO ...
doi: 10.1056/NEJMoa2016638. Forthcoming 2020. pmid:32492293. 128. Cohen MS. Hydroxychloroquine for the Prevention of Covid-19—Searching for ...
A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. N Engl J Med . 2020;383(6):517–525. doi:10.1056 ...
2020;doi:10.1056/NEJMoa2016638. Join the conversation: Share your thoughts on this editorial at healio.com/authors/draghavan. Published by ...
doi: 10.1056/NEJMoa2012410; Rosenberg JAMA . doi:10.1001/jama ... DOI: 10.1056/NEJMoa2016638. Articles in this issue. Previous slide
... 10.1056/NEJMoa2016638; Dexamethasone, COVID-19 and the RECOVERY trial. St Emlyn's https://www.stemlynsblog.org/dexamethasone-covid-19-and ...
https://www.nejm.org/doi/full/10.1056/NEJMoa2016638; Oxford RECOVERY Study: (UK) – Hospitalized Patients. “There was no significant ...
org/doi/full/10.1056/NEJMoa2016638 “We have concluded that there is no beneficial effect of hydroxychloroquine in patients hospitalised with ...
This article was published on June 3, 2020, at NEJM.org. N Engl J Med 2020;383:517-25. DOI: 10.1056/NEJMoa2016638. Copyright © 2020 ...
org/doi/full/10.1056/NEJMoa2016638?query=featur ed_coronavirus](https://l.facebook.com/l. php?u=https%3A%2F%2Fwww.nejm. org%2Fdoi%2Ffull ...
N Engl J Med 2020; NEJMoa2016638. doi: 10.1056/NEJMoa2016638. Medicines and Healthcare products Regulatory Agency. 2020. Available at ...
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
org/doi/full/10.1056/NEJMoa2016638?url_ver=Z39.8 8-2003&rfr_id=ori ... org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm.
#VisualAbstract: A randomized trial ...
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
org/doi/full/10.1056/NEJMoa2016638 18) RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a ...
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020: 1-9. 13. Catalan Ministry of Health ...
org/doi/full/10.1056/NEJMoa2016638 ,,. nejm.org. A Randomized Trial of Hydroxychloroquine as. 5 yrs. Jessie Bartmann PT. Sandra Ehlers my son ...
https://www.nejm.org/doi/full/10.1056/NEJMoa2016638. Happy to evaluate new evidence as it comes in, but right now the evidence is strongly ...
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org. Michael ...
Pullen was referring to “A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for COVID-19,” a paper published in early June ...
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
2020, DOI: 10.1056/NEJMoa2016638). Benjamin Rome, a primary care physician at Brigham and Women's Hospital, applauds the trial's rigor ...
A Randomised Trial of Hydroxychloroquine as Postexposure Prophylaxis for COVID-19. Boulware et al. NEJM; June 3 2020. doi:10.1056/NEJMoa2016638 ...
doi: 10.1056/NEJMoa2016638. Online ahead of print. PMID: 32492293. Share Facebook LinkedIn X Copy Link Print Email. Download the UMEM Pearls App ...
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for COVID-19. NEJM 2020. (Free Link). Clinical Question: Does HCQ ...
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
DOI: 10.1056/NEJMoa2016638. Source: https://www.nejm.org/doi/full/10.1056/NEJMoa2016638. 期刊信息. The New England Journal of Medicine:《新 ...
Larochelle- University of Minnesota - https://www.nejm.org/doi/full/10.1056/NEJMoa2016638?query=featured_home. Currently rated 3.0 by 2 ...
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
... warranted. mmortal03. • 6y ago. Yep, and a new study is also out: https://www.nejm.org/doi/full/10.1056/NEJMoa2016638. [deleted]. • 6y ago.
org/doi/full/10.1056/NEJMoa2016638?query=featur ed_coronavirus](https://l.facebook.com/l. php?u=https%3A%2F%2Fwww.nejm. org%2Fdoi%2Ffull ...
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
DOI: 10.1056/NEJMoa2016638. Journal information: New England Journal of Medicine. © 2020 AFP. + Explore further. Malaria drug shows no benefit ...
doi: 10.1056/NEJMoa2016638. M. S. Cohen. Hydroxychloroquine for the prevention of Covid-19 — Searching for evidence. New England Journal of ...
Original Study DOI: 10.1056/NEJMoa2016638. Related. How hydroxychloroquine causes heartbeat problems. Ethicist: Hydroxychloroquine hype could ...
... 10.1056/NEJMoa2016638). Eine Gruppe um Professor Dr. David Boulware von der University of Minnesota untersuchte darin in einem ...
... 10.1056/NEJMoa2016638 · None_of_your_Beezwax. • 6y ago ... 10.1056/NEJMoa2016638?query=featured_home#.XtgSPYeCao0.twitter · f3l1x.
doi.org/10.1056/NEJMoa2016638. Be the first to rate this article. Posted in: Drug Trial News | Disease/Infection News. Comments (0). Download ...
New England Journal of Medicine. doi: 10.1056/NEJMoa2016638. Share this article. facebook share Share on Facebook · twitter share ...
... 10.1056/NEJMoa2016638). Eine Gruppe um Professor Dr. David Boulware von der University of Minnesota untersuchte darin in einem ...
... bersama kajian itu. https://www.nejm.org/doi/full/10.1056/NEJMoa2016638?query=featured_home#.XtgSPYeCao0.twitter · f3l1x. • 6 thn lalu.
... Here's another trial in the US says no. https://www.nejm.org/doi/full/10.1056/NEJMoa2016638?query=featured_home. [deleted]. • 6y ago.
About the study. The study A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 was conducted by David R.
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Authors: David R. Boulware, M.D., M.P.H. https://orcid.org ...
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
org/doi/full/10.1056/NEJMoa2016638. nejm.org. A Randomized Trial of Hydroxychloroquine as. 5 años. 1. Foto del perfil de Esteban. Esteban ...
... ://www.nejm. org/doi/full/10.1056/NEJMoa2016638. nejm.org. A Randomized Trial of Hydroxychloroquine as. 5 yrs. 3. María Cristina Teran.
Pastick, B.Sc., et al. https://www.nejm.org/doi/full/10.1056/NEJMoa2016638?query=featured_home. Abstract. BACKGROUND. Coronavirus disease 2019 ...
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=tr ue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=tr ue). NEJM.ORG. www ...
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
2020;10.1056/NEJMoa2016638. doi:10.1056/NEJMoa2016638 PMID: 32492293 [free full text]. Cavalcanti AB, Zampieri FG, Rosa RG, et al ...
org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue](https://www.nejm. org/doi/pdf/10.1056/NEJMoa2016638?articleTools=t rue). www.nejm.org.
. DOI: 10.7326/M20-5041 DOI: 10.7326/M20-4207 DOI: 10.1056/NEJMoa2016638 DOI: 10.1136/bmj.m1849 DOI: 10.1056/NEJMoa2021436